Droperidol vs prochlorperazine for the treatment of acute headache
| Autor: | Edward J. Brizendine, Carey D. Chisholm, Christopher S. Weaver, Geoffrey G. Somerville, William H Cordell, James B. Jones, Michael J Foley, Beverly K. Giles |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
Adult
Male Adolescent Akathisia law.invention Prochlorperazine Randomized controlled trial law medicine Humans Droperidol Infusions Intravenous Aged Pain Measurement business.industry Incidence (epidemiology) Headache Nausea Emergency department Middle Aged Clinical trial Treatment Outcome Anesthesia Baseline characteristics Acute Disease Emergency Medicine Antiemetics Dopamine Antagonists Female medicine.symptom business medicine.drug Akathisia Drug-Induced |
| Zdroj: | The Journal of emergency medicine. 26(2) |
| ISSN: | 0736-4679 |
| Popis: | To determine if droperidol i.v. is as effective as prochlorperazine i.v. in the emergency department (ED) treatment of uncomplicated headache, a randomized, controlled, blinded study was conducted in the Emergency Departments of two urban teaching hospitals. Patients >or= 18 years old with crescendo-onset headache were eligible for inclusion. Ninety-six patients (48 in each group) were randomized to receive droperidol 2.5 mg i.v. or prochlorperazine 10 mg i.v. Baseline characteristics were similar between the two study groups. For the main study outcome, 83.3% in the droperidol group and 72.3% in the prochlorperazine group reported 50% pain reduction at 30 min (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect